CD8A and neoplasm: Such an enhanced cross-priming capacity of CD8+ T-cells was attributed to the improved antigen presentation by DCs (as assessed by the abundance of H-2Kb-SIINFEKL complexes on DCs from wild-type and Ythdf1−/− mice bearing B16-OVA tumours).